Back

General principles of drug–drug interactions in cardio-oncology

19 June 2026 (08:30 - 08:40)
Organised by: Logo
Congress Presentation Part of: Cardio-onco pharmacology: expanding the multidisciplinary team and facing new challenges Cardio-Oncology CCO Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Doctor Bernadette Aretin

Medical University of Vienna, Vienna (Austria)

3 More presentations in this session

Presentation thumbnail
How to report cardiovascular side effects: practical guidance
Doctor C. Dolladille (Caen, FR)
Slides
Presentation thumbnail
QT prolongation in cardio-oncology: understanding the risk
Doctor M. Fradley (Philadelphia, US)
Slides
Presentation thumbnail
Cardio-Onco Pharmacology: expanding the multidisciplinary team and facing new challenges - discussion

Access the full session

Session thumbnail
Cardio-onco pharmacology: expanding the multidisciplinary team and facing new challenges
Video

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Incidence of drug-drug interactions of QT-prolonging drugs in an onco-hematological outpatient
27 August 2022
thumbnail
Congress Session
Young Investigator Award (YIA) Basic Science
17 May 2025
thumbnail
Congress Session
Cardio-oncology: when therapy leads to failure
17 May 2025
thumbnail
Congress Presentation
Stop cardiotoxicity: the role of statin therapy in anthracycline treated patients
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources